Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
An analysis of the structual binding and potency of vascular endothelial growth factor receptor (VEGFR) inhibitors indicates that the inclusion of interactions with the juxtamemebrane domain better reflects the efficacy of these drugs in renal cell carcinoma.
A new mouse model of adoptive cell transfer for the treatment of melanoma indicates that dedifferentiation of melanoma cells, driven by an inflammatory response, might have a role in resistance.
A pathway in which alternative splicing of histone variant isoforms regulates transcription of redox metabolism genes has been shown to have a role in tumour cell invasion and might be relevant in human breast cancer.
Two papers report that combined inhibition of PI3K and poly(ADP) ribose polymerase (PARP) is synergistic in BRCA1-defective and BRCA-proficient triple-negative breast cancer.
Reactivation of dormant breast cancer cells at metastatic sites may require these cells to overcome organ-specific suppressive signals in the microenvironment and to activate stem cell-like traits.